|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bullous Pemphigoid | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Pemphigoid, Bullous | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| Skin Diseases, Vesiculobullous | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Azathioprine | |||||
| Mycophenolate mofetil | |||||
| Mycophenolic Acid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antibiotics, Antineoplastic | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University Hospital Muenster | |||||
| Hoffmann-La Roche | |||||